Skip to main content
Clinical Trials/ISRCTN17230715
ISRCTN17230715
Completed
未知

A dietary supplement for the management of patients with lumbar osteochondrosis

Austrian Research group for Regenerative and Orthopedic Medicine (AURROM)0 sites50 target enrollmentApril 28, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Austrian Research group for Regenerative and Orthopedic Medicine (AURROM)
Enrollment
50
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2021
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Austrian Research group for Regenerative and Orthopedic Medicine (AURROM)

Eligibility Criteria

Inclusion Criteria

  • 1\. Female and male patients aged between 18 and 75 years of age
  • 2\. Patients with symptomatic (VAS \=4\) MRI\-confirmed lumbar osteochondrosis

Exclusion Criteria

  • 1\. Patients with asymptomatic (VAS \= 3\) MRI\-confirmed (Pfirrmann grades 1 and 5 lumbar osteochondrosis
  • 2\. Patients with pathologies including
  • 2\.1\. Rheumatoid osteoarthritis
  • 2\.2\. Fibromyalgia
  • 2\.3\. Scoliosis
  • 2\.4\. Neurological deficit
  • 2\.5\. Morbid adiposity (body mass index, BMI \=40\)
  • 2\.6\. Any other current or past clinically significant disease (comorbidity) that, in the opinion of the orthopaedic consultant, might confound the results of the study or poses an additional risk to the subject during participation in the study (e.g. renal, neoplastic, epigastric disease)
  • 3\. Previous surgeries of intervertebral disc(s), hip(s)
  • 4\. Allergies/intolerances against any component of the dietary supplement (e.g. shellfish)

Outcomes

Primary Outcomes

Not specified

Similar Trials